SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Share Price near 52-week high as stock trades at Rs 346.50
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
SURAKSHA Share Price is Rs 346.50, up 3.11%, and trading near its 52-week high with market cap at Rs 1,750.17 crore.
SURAKSHA Share Price is in focus after SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) traded at Rs 346.50, up Rs 10.45 or 3.11%, in afternoon trade on 21 September 2026 at 3:18 PM IST. The stock is close to its 52-week high zone after touching Rs 359 during the day, while the company’s market capitalisation stood at Rs 1,750.17 crore. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. That makes today’s move relevant for readers tracking SURAKSHA Share Price Today, SURAKSHA Stock News and the broader 52-week high theme in the healthcare space.
For investors following SURAKSHA Share Price, the key takeaway is that the stock is trading above its previous close of Rs 336.05 and above its opening level of Rs 337.55, which keeps the discussion centred on the current price action rather than on any unverified trigger. The stock’s intraday range stretched from Rs 335 to Rs 359, and turnover stood at Rs 1.19 crore. In other words, the latest Univest figures show a firm session for SURAKSHA Share Price Today, with the one-year high narrative staying front and centre in searches such as SURAKSHA News Today and SURAKSHA Share News.
SURAKSHA Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 346.5 |
| Previous Close | Rs 336.05 |
| Today's Move | +Rs 10.45 (+3.11%) |
| Open | Rs 337.55 |
| High | Rs 359 |
| Low | Rs 335 |
| Turnover | Rs 1.19 crore |
| Market Capitalisation | Rs 1,750.17 crore |
SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) traded at Rs 346.5 versus the previous close of Rs 336.05, a rise of 3.11%. The stock opened at Rs 337.55, reached a high of Rs 359 and touched a low of Rs 335.
SURAKSHA Share Price Today reflects a clear positive move versus the previous close. The stock opened at Rs 337.55, spent the day between Rs 335 and Rs 359, and last traded at Rs 346.50. That places the move at Rs 10.45 above the previous close and leaves the stock about 3.54% below the day’s high of Rs 359. The turnover of Rs 1.19 crore shows the value traded during the live session, while the daily gain of 3.11% keeps SURAKSHA Stock News in focus for readers scanning Stocks in News and 52 Week High Stocks.
Since the stock is trading close to its 52-week high, the near-high event is now part of the market conversation around SURAKSHA Share Price Update and SURAKSHA Share Price Live. The price action confirms the event condition, but the latest Univest data does not establish a company-specific catalyst. For that reason, the next section turns to SURAKSHA Fundamental Analysis and the numbers that frame valuation.
SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,750.17 crore |
| P/E Ratio | 48.89x |
| P/B Ratio | 6.82x |
| ROE | 13.81% |
| ROCE | 24.97% |
| EPS | Rs 6.87 |
| Book Value Per Share | Rs 49.28 |
| Dividend Yield | 0.15% |
SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) fundamental metrics show P/E 48.89x, P/B 6.82x, ROE 13.81%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.
SURAKSHA DIAGNOSTIC LIMITED has a market capitalisation of Rs 1750.17 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.89x, P/B at 6.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.81% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.87, book value per share of Rs 49.28, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.56x, median ROE of 12.88%, median ROCE of 15.77%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 48.89x |
| Benchmark Median P/E | 44.56x |
| Benchmark Average P/E | 90.9x |
| Benchmark P/E Range | 0x to 1,595.77x |
| Company P/B Ratio | 6.82x |
| Benchmark Median P/B | 3.03x |
| Company ROE | 13.81% |
| Benchmark Median ROE | 12.88% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 15.77% |
| Company Market Capitalisation | Rs 1,750.17 crore |
| Benchmark Median Market Cap | Rs 479.68 crore |
SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P/E ratio of 48.89x, which is above the benchmark median of 44.56x, a difference of +9.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROE of 13.81%, which is above the benchmark median of 12.88%, a difference of +7.22%. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROCE of 24.97%, which is above the benchmark median of 15.77%, a difference of +58.34%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Krsnaa Diagnostics Ltd. | KRSNAA | 1,756.55 | 18.02 | 1.78 | 10.97 | 13.08 |
| Shalby Ltd. | SHALBY | 1,488.91 | 37.87 | 1.47 | 3.48 | 6.88 |
| GUJARAT KIDNEY N SUP SP L | GKSL | 1,431.79 | 90.42 | 5.55 | 68.65 | 63.02 |
| GPT Healthcare Ltd. | GPTHEALTH | 1,361.29 | 28.8 | 4.82 | 16.32 | 23.06 |
| KMC Speciality Hospitals (India) Ltd. | KMCSHIL | 2,452.8 | 43.98 | 10.81 | 24.94 | 27.25 |
SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P/E ratio of 48.89x compared with the displayed peer median of 37.87x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.81% compares with a peer median of 16.32% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 23.06%, providing a capital-efficiency comparison. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a market capitalisation of Rs 1,750.17 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching SURAKSHA
- SURAKSHA Share Price is Rs 346.50, up 3.11% from the previous close of Rs 336.05.
- The stock touched Rs 359 during the day and is trading near its 52-week high.
- Market capitalisation stands at Rs 1,750.17 crore, which places the company above the industry median market cap.
- P/E is 48.89 and P/B is 6.82, both important for SURAKSHA Fundamental Analysis.
- ROE is 13.81% and ROCE is 24.97%, which gives the stock a profitability and capital-efficiency reference point.
About SURAKSHA
SURAKSHA DIAGNOSTIC LIMITED operates in Healthcare and is classified in the Hospital & Healthcare Services industry. The company is tracked on NSE and BSE under the symbol SURAKSHA. Its latest reported financials show revenue growth from Rs 725.86 crore in Jun 2025 to Rs 876.08 crore over the same period. Those figures help frame SURAKSHA Stock News and SURAKSHA Share Price Today within a broader company overview.
For readers following SURAKSHA Latest News, the company’s book value of 49.28, EPS of 6.87 and dividend yield of 0.15% are part of the current fundamental picture. Univest tracks SURAKSHA Share Price alongside these metrics so that readers can connect live price action with valuation, business performance and sector context.
Frequently Asked Questions
What is SURAKSHA Share Price today?
Ans. SURAKSHA Share Price is Rs 346.50 in afternoon trade on 21 September 2026. It is up Rs 10.45, or 3.11%, from the previous close of Rs 336.05. The intraday range extended from Rs 335 to Rs 359.
Why is SURAKSHA Share Price in focus today?
Ans. SURAKSHA Share Price is in focus because the stock is trading near its 52-week high and has moved to Rs 346.50 during the session. The price event is confirmed by latest Univest data.
How far is SURAKSHA from its day high?
Ans. SURAKSHA last traded at Rs 346.50 after touching a high of Rs 359 during the day. That leaves the stock about Rs 12.50 below the intraday peak.
What is SURAKSHA market capitalisation?
Ans. SURAKSHA market capitalisation stands at Rs 1,750.17 crore. That figure places the company above the industry median market cap in the latest same-industry benchmark set. The company operates in the Healthcare sector.
What does SURAKSHA P/E ratio indicate?
Ans. SURAKSHA trades at a P/E ratio of 48.89. In the latest healthcare industry benchmark, that is above the median P/E of 44.56 and below the industry average of 90.9.
How do SURAKSHA ROE and ROCE compare with peers?
Ans. SURAKSHA reports ROE of 13.81% and ROCE of 24.97%. Those figures are above Krsnaa Diagnostics on both measures and slightly above GPT Healthcare on ROCE. The relevant peer median ROE is 12.88%.
What are SURAKSHA EPS and book value?
Ans. SURAKSHA EPS is 6.87 and book value is 49.28. These figures help frame earnings per share and the accounting net worth behind each share for SURAKSHA Share Price analysis.
How does SURAKSHA compare with healthcare peers?
Ans. SURAKSHA compares closely on market cap with Krsnaa Diagnostics, while its P/E and P/B sit above some peers and below others. ROCE is stronger than several listed healthcare comparables.
Track SURAKSHA Share Price on Univest
Use SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track SURAKSHA Share Price on Univest for live price updates, market capitalisation, key valuation ratios, financial results, sector context and 52-week levels. Univest also helps readers follow SURAKSHA Share Price Today, SURAKSHA Stock Analysis and broader market insights in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).